Expression of amyloid precursor protein in human astrocytes in vitro: Isoform-specific increases following heat shock

Neuroscience

Volumn 99, Issue 2, 2000, Pages 317-325

  Shepherd, C E ^a   Bowes, S ^b   Parkinson, D ^b   Cambray Deakin, M ^a   Pearson, R C A ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

Author keywords

Alzheimer's disease; Astrocytes; Heat shock; In situ hybridization histochemistry; In vitro; Kunitz protease inhibitor

Indexed keywords

AMYLOID PRECURSOR PROTEIN; MESSENGER RNA;

ARTICLE; ASTROCYTE; HEAT SHOCK; HISTOCHEMISTRY; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN PRECURSOR; ASTROCYTES; CELL LINE; HEAT STROKE; HEAT-SHOCK RESPONSE; HUMANS; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 0034638240     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00197-4     Document Type: Article

References (50)

1. Abe K., St George-Hyslop P.H., Tanzi R.E., Kogure K. Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells. Neurosci. Lett. 125:1991;169-171.
2. Arai H., Leigh V.M.Y., Messinger I.L., Greenberg B.D., Lowery D.E., et al. Expression patterns of β amyloid precursor protein (β-APP) in neural and non neural human tissues from Alzheimer's disease and control subjects. Ann. Neurol. 30:1991;686-693.
3. Chopp M. The roles of heat shock proteins and immediate early genes in central nervous system normal function and pathology. Curr. Sci. 6:1993;6-10.
4. Ciallella J.R., Rangnekar V.V., McGillis J.P. Heat shock alters Alzheimer's β-amyloid precursor protein expression in human endothelial cells. J. Neurosci. 37:1994;769-776.
5. Clark M.J., Gagnon J., Williams A.F., Barclay A.N. MRC OX-2 antigen: a lymphoid/neuronal membrane glycoprotein with a structure like a single immunoglobin light chain. Eur. molec. Biol. Org. J. 4:1985;113-118.
6. Cohen M.L., Golde T.E., Usiak M.F., Younkin L.H., Younkin S.G. In situ hybridisation of nucleus basalis neurons shows increased beta-amyloid messenger-RNA in Alzheimer's-disease. Proc. natn. Acad. Sci. USA. 85:1988;1227-1231.
7. Dewji N.N., Do C., Bayney R.M. Transcriptional activation of Alzheimer's β amyloid precursor protein gene by stress. Molec. Brain Res. 33:1995;245-253.
8. Forloni G., Demicheli F., Georgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial neuronal and glial cell modulation by interleukin-1. Molec. Brain Res. 16:1992;128-134.
9. Gegelashvili G., Bock E., Schousboe A., Linnemann X. Two types of amyloid precursor protein (APP) mRNA in rat glioma cell lines: upregulation via a cyclic AMP-dependent pathway. Molec. Brain Res. 37:1996;151-156.
10. Glenner G.G., Wong C.W. Alzheimer's-disease - initial report of the purification and characterisation of a novel cerebrovascular amyloid protein. Biochem. biophys. Res. Commun. 120:1984;885-890.
11. Goedert M. Neuronal localisation of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. Eur. molec. Biol. Org. J. 6:1987;3627-3632.
12. Golde T.E., Estus S., Usiak M., Younkin L.H., Younkin S.G. Expression of β amyloid protein precursor mRNA recognition of a novel alternatively spliced form and quantitation in Alzheimer's disease using PCR. Neuron. 4:1990;253-267.
13. Goldgaber D., Harris H.W., Hia T., Macaig T., Donnely R.J., et al. Interleukin 1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proc. natn. Acad. Sci. USA. 86:1989;7606-7610.
14. Goldman J.E., Yen S.H. Cytoskeletal protein abnormalities in neurodegenerative diseases. Ann. Neurol. 19:1986;209-223.
15. Gray C.W., Patel A.J. Induction of B-amyloid precursor protein isoform mRNAs by bFGF in astrocytes. NeuroReport. 4:1993;811-814.
16. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., et al. Abnormal phosphorylation of the microtubule-associated protein-tau (tau) in Alzheimer's cytoskeletal pathology. Proc. natn. Acad. Sci. USA. 83:1986;4913-4917.
17. Haass C., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., et al. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-327.
18. Hamos J.E., Oblas B., Pulaski-Salo D., Welch W.J., Bole D.G., et al. Expression of heat shock proteins in Alzheimer's disease. Neurology. 41:1991;345-350.
19. Harrison P.J., Barton A.J.L., Procter A.W., Bowen D.M., Pearson R.C.A. The effects of Alzheimer's-disease, other dementias, and premortem course on beta-amyloid precursor protein messenger-RNA in frontal-cortex. J. Neurochem. 62:1994;635-644.
20. Ho L., Fukuchi K.I., Younkin S.G. The alternatively spliced Kunitz protease inhibitor domain alters amyloid B protein precursor processing and amyloid B protein production in cultured cells. J. biol. Chem. 271:1996;30,929-30,934.
21. Hyman B.T., Tanzi R.E., Marzloff K., Barbour R., Shenk D., et al. Kunitz protease inhibitor-containing amyloid β protein precursor immunoreactivity in Alzheimer's disease. J. Neuropath. exp. Neurol. 51:1992;76-83.
22. Johnson G., Refolo L.M., Merril C.R., Wallace W. Altered expression and phosphorylation of amyloid precursor protein in heat shocked and neuronal PC12 cells. Molec. Brain Res. 19:1993;140-148.
23. Johnson S.A., Mcneill T., Cordell B., Finch C.E. Relation of neuronal APP-751/APP-695 messenger-RNA ratio and neuritic plaque density in Alzheimer's-disease. Science. 248:1990;854-857.
24. Johnston J.A., Norgren S., Anneren G., Cowburn R.F., Lannfelt L. A new quantitative solution hybridisation-RNase protection assay for APP and APLP2 mRNA. Molec. Brain Res. 43:1996;77-84.
25. Kang J., Lemeire H.G., Utterbeck A., Salbaum J.M., Masters C.L., et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 325:1987;733-736.
26. Kim K.S., Wen G.Y., Bancher C., Chen C.M.J., Sapienza V.J., Hong H., Wisniewski H.M. Detection and quantitation of amyloid b-peptide with two monoclonal antibodies. Neurosci. Res. Commun. 7:1990;113-122.
27. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's-disease protein shows protease inhibitory activity. Nature. 331:1988;530-532.
28. Konig G., Monning U., Czech C., Prior R., Banati R., et al. Identification and differential expression of a novel alternative splice isoform of the beta-a4 amyloid precursor protein (APP) messenger-RNA in leukocytes and brain microglial cells. J. biol. Chem. 267:1992;10,804-10,809.
29. Konig G., Salbaum J.M., Wiestler O., Lang W., Schmitt H.P., et al. Alternative splicing of the β-a4 amyloid gene of Alzheimer's-disease in cortex of control and Alzheimer's-disease patients. Molec. Brain Res. 9:1991;259-262.
30. Masters C.L., Simms G., Weinman N.A., Multhaup G., Mcdonald B.L., et al. Amyloid plaque core protein in Alzheimer's-disease and Down syndrome. Proc. natn. Acad. Sci. USA. 82:1985;4245-4249.
31. Moir R.D., Lynch T., Bush A.I., Whyte S., Henry A., et al. Relative increase in Alzheimer's disease of soluble forms of cerebral a beta amyloid protein precursor containing the Kunitz protease inhibitory domain. J. biol. Chem. 273:1998;5013-5019.
32. Mori H., Kondo J., Ihara Y. Ubiquitin is a component of paired helical filaments in Alzheimer's-disease. Science. 235:1987;1641-1644.
33. Perez N., Sugar J., Charya S., Johnson G., Merril C., et al. Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease. Molec. Brain Res. 11:1991;249-254.
34. Ponte P., Gonzalezdewhitt P., Schilling J., Miller J., Hsu D., et al. A new A4-amyloid messenger-RNA contains a domain homologous to serine proteinase-inhibitors. Nature. 331:1988;525-527.
35. Ramakrishna N., Smedman M., Gillan B. Suppression of Alzheimer Amyloid Precursor Protein (APP) expression by exogenous APP mRNA. Archs Biochem. Biophys. 326:1996;243-251.
36. Rockenstein E.M., McConlogue L., Tan H., Power M., Masliah E., et al. Levels and alternative splicing of amyloid-beta protein-precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's-disease. J. biol. Chem. 270:1995;28,257-28,267.
37. Salbaum M., Weidermann A., Lemaire G., Masters C.L., Beyreuther K. The promoter of Alzheimer's disease amyloid A4 precursor gene. Eur. molec. Biol. Org. J. 7:1988;2807-2813.
38. Seubert P., Vigro-Pelfrey C., Esch F., Lee M., Dovey H., et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-330.
39. Shepherd C.E., Calvert E.L., Cambray-Deakin M.A., Pearson R.C.A. Expression of Alzheimer's disease related genes in three human astrocytic cell lines. Soc. Neurosci. Abstr. 23:1997;266.
40. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., et al. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
41. Siman R., Card J.P., Nelson R.B., Davis L.G. Expression of β-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron. 3:1989;275-285.
42. Sola C., Garcia-Ladona F.J., Mengod G., Probst A., Frey P., et al. Increased levels of the Kunitz protease inhibitor domain-containing BAPP mRNAs in rat brain following neurotoxic damage. Molec. Brain Res. 17:1993;41-52.
43. Spillantini M.G., Hunt S.P., Ulrich J., Goedert M. Expression and cellular-localisation of amyloid beta-protein precursor transcripts in normal human-brain and in Alzheimer's-disease. Molec. Brain Res. 6:1989;143-150.
44. Sudoh S., Kawakami H., Nakamura S. Serum deprivation alters the expression and the splicing at exons 7, 8 and 15 of the β-amyloid precursor protein in the C6 glioma cell line. Molec. Brain Res. 39:1996;12-22.
45. Tanaka S., Shiojiri S., Takahashi Y., Kitaguchi N., Ito H., et al. Tissue-specific expression of 3 types of beta-protein precursor messenger-RNA - enhancement of protease inhibitor-harbouring types in Alzheimer's-disease brain. Biochem. biophys. Res. Commun. 165:1989;1406-1414.
46. Tanzi R.E., Mcclatchey A.I., Lamperti E.D., Villakomaroff L., Gusella J.F., et al. Protease inhibitor domain encoded by an amyloid protein-precursor messenger-RNA associated with Alzheimer's-disease. Nature. 331:1988;528-530.
47. Webster M.T., Groome N., Francis P.T., Pearce B.R., Sherriff F.E., et al. A novel protein, amyloid precursor-like protein-2, is present in human brain, cerebrospinal-fluid and conditioned media. Biochem. J. 310:1995;95-99.
48. Weidermann A., Konig G., Bunke D., Fischer P., Salbaum J.M., et al. Identification, biogenesis, and localisation of precursors of Alzheimer's disease A4 amyloid protein. Cell. 57:1989;115-126.
49. Wighton-Benn W., Vardy E., Heath P.R., Pearson R.C.A. Alterations in mRNAs encoding major isoforms of APP in the AD neocortex. Soc. Neurosci. Abstr. 85:1995;4.
50. Yankner B.A., Dawes L.R., Fisher S., Villakomaroff L., Ostergranite M.L., et al. Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's-disease. Science. 245:1989;417-420.